Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silenor vs Zolpidem on Arousability and Balance in Healthy Volunteers
NCT02353299Phase 4Completed
- Sponsor
- Currax Pharmaceuticals LLC
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxepin in Insomnia, sponsored by Currax Pharmaceuticals LLC. Started Jan 2015; status: completed.
02
Drugs
doxepin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02353299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353299.